Nmnh
[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
Molecular Identity
Nmnh
[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
PubChem CID: 9974249
NMNH is a nicotinamide mononucleotide that is obtained by addition of hydride to position 4 on the pyridine ring of NMN+. It has a role as a metabolite. It is functionally related to a NMN(+). It is a conjugate acid of a NMNH(2-).
2D Structure
Properties
C11H17N2O8P
Molecular Formula
336.23
Molecular Weight
g/mol
336.0723
Exact Mass
Da
-3.2
XLogP
Drug-like (Lipinski: < 5)
163
TPSA
May have limited oral absorption
5
H-Bond Donors
9
H-Bond Acceptors
544
Complexity
SMILES
Canonical SMILES
SMILES: C1C=CN(C=C1C(=O)N)C2C(C(C(O2)COP(=O)(O)O)O)OIsomeric SMILES
SMILES: C1C=CN(C=C1C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)OSynonyms(18)
NMNHCHEBI:74452RefChem:10924841-((2R,3R,4S,5R)-3,4-dihydroxy-5-((phosphonooxy)methyl)oxolan-2-yl)-1,4-dihydropyridine-3-carboximidic acid4229-56-51-(5-O-phosphono-beta-D-ribofuranosyl)-1,4-dihydropyridine-3-carboxamide((2R,3S,4R,5R)-5-(3-Carbamoylpyridin-1(4H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate1,4-Dihydronicotinamide mononucleotide[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphateReduced nicotinamide nucleotideCHEMBL2058993SCHEMBL23956523C11H17N2O8PDTXSID301375500C21113
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Nmnh
Loading drug network...